Cambridge Healthtech Institute

1,500 attendees. 300 speakers. 250+ posters. One summit. Join Europe's leading protein & antibody engineering community in Lisbon this November. Register today!

Registration Deadline this Friday for PEGS Europe https://lnkd.in/ge4ZTX5 To see for yourself why #PEGSEurope has been described as the "best biologics technology meeting in Europe", enjoy this short video. If you plan to join us in beautiful Lisbon, register today for maximum savings. The "Emerging Modalities & Future of Antibody Engineering" plenary session will include Jennifer Cochran, Ulrike Philippar, Roland Kontermann & Patrick Baeuerle. New this year is expanded coverage of AI/ML applications in #proteinengineering, multispecific antibodies, T-cell engagers, #biologics for #autoimmune diseases, next-generation conjugates, emerging targets, oncology, expression, novel #peptide drug discovery, analytical characterisation, plus five Training Seminars, and three Short Courses. Christina Lingham Mimi Langley MaryAnn Brown Iris Goldman Kent Simmons

Join over 1,500 biologics industry professionals at the 18th Annual PEGS Europe in Lisbon this November. Hear from 300+ speakers, explore 250+ scientific posters, and discuss the latest breakthroughs in protein and antibody engineering. Secure your pass today: https://lnkd.in/ge4ZTX5

1,500+ scientists. 300 speakers. One event covering everything from bispecifics to AI-driven protein design. PEGS Europe brings together the biologics community working on antibody engineering, immunotherapy, ADCs, T cell engagers, and next-gen protein science. Described by attendees as "the best biologics technology meeting in Europe." 📍 16–19 November 2026 | Lisbon, Portugal

Ready to explore tomorrow's therapeutics? Join over 250 of your peers at Drug Discovery Chemistry Europe in Barcelona this 10-12 November 2026. Dive into practical discussions on the most pressing challenges in small molecule drug discovery, featuring insights from leaders at AstraZeneca, Genentech, GSK, and Merck. Key Conference Tracks: - AI/ML for Early Drug Discovery - Next-Gen Degraders & Molecular Glues - Lead Generation Strategies - Targeting Protein-Protein Interactions (PPIs) Book early to save on your registration. Click below to view the full agenda and secure your pass!

The discovery timeline is collapsing. AI is resetting the tempo, and new modalities are redefining what’s "druggable." At Drug Discovery Chemistry Europe, we’re bringing together hundreds of R&D leaders to bridge the gap between computational power and medicinal chemistry. Why attend? - Track-Hop: Seamlessly move between AI/ML, PPI, and Degrader tracks. - 1:1 Networking: Pre-scheduled meetings with decision-makers from Merck, AstraZeneca, and Novartis. - Real-World Case Studies: See how peers are triaging virtual libraries and accelerating hit-to-lead. Secure your spot in Barcelona this November. Learn more today!